Recombinant Human BAFF-R protein (Fc tag C-Terminus + Avi tag C-Terminus)
Be the first to review this product! 리뷰 제출
|
(0 출판물)
Recombinant Human BAFF-R protein (Fc tag C-Terminus + Avi tag C-Terminus) is a Human Fragment protein, in the 23 to 71 aa range, expressed in HEK 293 cells, with >90%, suitable for SDS-PAGE.
대체 명칭 보기
CD268, BAFFR, BR3, TNFRSF13C, Tumor necrosis factor receptor superfamily member 13C, B-cell-activating factor receptor, BAFF receptor, BLyS receptor 3, BAFF-R
- SDS-PAGE
Supplier Data
SDS-PAGE - Recombinant Human BAFF-R protein (Fc tag C-Terminus + Avi tag C-Terminus) (AB271388)
SDS-PAGE analysis of 4 μg ab271388.
Reactivity 정보
서열 정보
특성 및 보관 정보
제형
배송 시 보관 조건
적절한 단기 보관 조건
적절한 장기 보관 조건
보관 정보
추가 정보
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
BAFF-R is essential for the maturation and maintenance of peripheral B cells. The receptor contributes to the regulation of immune responses by ensuring B-cell homeostasis. It does not generally form part of a larger protein complex but instead functions as a membrane-bound receptor that transmits signals upon binding with the BAFF ligand. This signaling cascade supports the survival and proliferation of B cells which is fundamental for the adaptive immune system.
Pathways
BAFF-R is deeply involved in the NF-κB signaling pathway which is important for immune regulation and cell survival. Upon binding with BAFF BAFF-R recruits associated proteins to initiate the pathway and as a result promotes gene transcription important for B-cell function. Another connected pathway involves AKT a protein kinase that regulates B-cell metabolism and differentiation. Both NF-κB and AKT pathways help facilitate the immune functions tied to B cells directly through BAFF-R signaling.
일반 정보
기능
B-cell receptor specific for TNFSF13B/TALL1/BAFF/BLyS. Promotes the survival of mature B-cells and the B-cell response.
타겟 정보
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com